Cambridge Research Station is part of a joint program between the Cambridge Research Institute and Cryer Pharmaceuticals. The station pursues a broad range of research, but primarily focuses on the development of medicines and bioware that require a zero-g environment.
Attributes | Values |
---|---|
rdfs:label |
|
rdfs:comment |
|
dcterms:subject | |
abstract |
|